FDA Center for Drug Evaluation & Research Issues Warning Letter to Thomas Brunner Hygiene GmbH
August 05, 2026
August 05, 2026
WASHINGTON, Aug. 5 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Thomas Brunner Hygiene GmbH from its Center for Drug Evaluation and Research:
* * *
Recipient: Thomas Brunner, Managing Director, Thomas Brunner Hygiene GmbH, Carl-Benz-Strasse 7 Albershausen, 73095 Baden-Wurttemberg, Germany, tbrunner3@syneo.de
Issuing Office: Center for Drug Evaluation and Research (CDER), United State . . .
* * *
Recipient: Thomas Brunner, Managing Director, Thomas Brunner Hygiene GmbH, Carl-Benz-Strasse 7 Albershausen, 73095 Baden-Wurttemberg, Germany, tbrunner3@syneo.de
Issuing Office: Center for Drug Evaluation and Research (CDER), United State . . .